Vital Farms, Inc.
No enriched coverage for $VITL in the last 7 days.
No SEC Form 4 filings for $VITL in the last 30 days.
See all $VITL insider activity →Jefferies maintained a $15 price target on Vital Farms (VITL), citing pressure from easing egg prices and rebuilding layer flocks. USDA forecasts a 2026 egg price of $1.07/dozen, with spot prices at 65 cents. Vital Farms' volumes fell 6% YoY, but demand for pasture-raised eggs remains strong, growing 17% YoY.
Vital Farms (VITL) shares fell 8.8% to $10.26 after Axios reported the company is considering strategic alternatives, including a take-private deal. The market value has dropped over 80% from its peak. Analysts have differing views on the stock's potential, with one setting a $18 price target. The stock is down 65.8% year-to-date and 77.2% from its 52-week high.
Vital Farms (VITL) stock rose 7.5% pre-market after reports it is exploring strategic options, including a potential sale, with a valuation range of $15–$25 per share. StoneX reiterated a Buy rating and $18 target. The S&P 500, Dow Jones, and NASDAQ also gained 1.3%–1.7%, supporting the rally.
Recent VITL coverage spans earnings, market movers and financial news.
Analyst maintains target despite pricing pressure, suggesting limited upside.
The price drop reflects market reaction to speculation about a potential take‑private transaction.
The strategic review creates immediate upside potential and may trigger further buying pressure.
The rally reflects short‑term buying pressure from analysts and passive fund inflows.
The earnings print plus new North American acquisition pipeline and balance-sheet actions (European portfolio sale, debt repayments) can shift near-term AFFO expectations and risk perception.
AlphAI scores every news story that mentions VITL with an AI model for sentiment and relevance, and aggregates insider trades from Vital Farms, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
Jefferies maintained a $15 price target on Vital Farms (VITL), citing pressure from easing egg prices and rebuilding layer flocks. USDA forecasts a 2026 egg price of $1.07/dozen, with spot prices at 65 cents. Vital Farms' volumes fell 6% YoY, but demand for pasture-raised eggs remains strong, growing 17% YoY.
1 min readVital Farms (VITL) shares fell 8.8% to $10.26 after Axios reported the company is considering strategic alternatives, including a take-private deal. The market value has dropped over 80% from its peak. Analysts have differing views on the stock's potential, with one setting a $18 price target. The stock is down 65.8% year-to-date and 77.2% from its 52-week high.
2 min readVital Farms (VITL) stock rose 7.5% pre-market after reports it is exploring strategic options, including a potential sale, with a valuation range of $15–$25 per share. StoneX reiterated a Buy rating and $18 target. The S&P 500, Dow Jones, and NASDAQ also gained 1.3%–1.7%, supporting the rally.
2 min readVital Farms (VITL) stock rose 5.4% to $11.15, extending a recovery from multi-year lows. Recent developments include Q2 revenue slightly above estimates, reaffirmed full-year guidance, analyst upgrades, and inclusion in Russell value indices. The stock remains volatile and below its 52-week high of $53.13.
1 min readVital Infrastructure Property Trust (TSX: VITL.UN) reported Q2 2026 results for the three and six months ended June 30, 2026. Net income fell to $0.3 million from $32.6 million a year earlier, while AFFO rose to $0.11 per unit. The REIT generated about $145 million net cash from selling its European portfolio and, after quarter end, bought a Brooklyn health hub for US$89.9 million and agreed to buy a Canadian outpatient facility for about $26.2 million.
6 min readVital Farms (NASDAQ: VITL) shares rose about 3.9% after the company reported Q2 results. Revenue fell 10.1% year over year to $166 million, and the company swung to a net loss of $0.72 per share versus a $0.36 profit a year earlier. Gross margin dropped to 6.6% from 38.9%. Vital Farms reaffirmed full-year revenue guidance.
4 min readVital Farms (NASDAQ:VITL) reported Q2 CY2026 sales of $166 million, down 10.1% year over year, but slightly above Wall Street estimates. Full-year revenue guidance was $787.5 million at the midpoint, 1.7% above consensus. GAAP loss was $0.72 per share, 51.4% better than expected. The article also cites negative free cash flow and cash burn in Q2.
4 min readVital Farms, Inc. (VITL) filed an SEC Form 8-K — Results of Operations and Financial Condition. Vital Farms Reports Second Quarter 2026 Financial Results Second Quarter Net Revenue of $166.0 Million Announces Successful Execution of Previously Disclosed Supply Control and Targeted Cost Savings Initiatives Grew Retail Dollar Share of the Shell Egg Category by More Than 200 B
6 min readVital Infrastructure Property Trust (TSX: VITL.UN) said it acquired the East New York Health Hub in Brooklyn, a 142,249 sq ft, seven-storey outpatient medical facility completed in 2019, for $126.7 million (US$89.9 million). The property is leased to AdvantageCare Physicians New York with about 11 years remaining and is expected to be immediately accretive to FFO per unit.
2 min readAn earnings roundup covers perishable food companies. United Natural Foods (UNFI) shares rose 11.9% to $88.55 after reporting. Vital Farms (VITL) revenue was $187.2M (+15.4% YoY), beating estimates, but guidance missed; stock up 11.1% to $13.33. Beyond Meat (BYND) revenue was $58.21M (-15.3%), below estimates; stock down 42.2% to $0.60. Flowers Foods (FLO) revenue was $1.57B (+1.1%), meeting estimates; stock up 21.2% to $8.50.
6 min read
